The exact dose ranges, how adjustments will work in everyday use, and long-term recommendations are still being studied
These treatments should be offered to adults who meet all of the following: At least one weight-related comorbidity (such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease) BMI of 35 kg/m or above (or 32.5 kg/m or above for people from South Asian, Chinese, other Asian, Middle Eastern, Black African, or African-Caribbean backgrounds) Access to a specialist weight management service that provides multidisciplinary support, including dietary advice, physical activity programmes, and behavioural interventions Treatment is typically time-limited to up to 2 years Previous unsuccessful attempts at weight loss through lifestyle measures alone Orlistat may be considered for adults with a BMI of 28 kg/m or above with associated risk factors (such as type 2 diabetes or cardiovascular disease), or 30 kg/m or above without additional risk factors
Hepatology 56 , 20272038 (2012)
The triple mechanism produces substantially greater weight loss
Thats why weve curated the Daily Harvest GLP-1 Support Box, a collection of convenient, nutrient-dense options designed specifically for GLP-1 users
Understanding the triggers of melasma is essential for effective management
.png)
